Antonio Gidaro, Federica Samartin, Emanuele Salvi, Francesco Casella, Chiara Cogliati, Davide Giustivi, Francesca Lugli, Chiara Trione, Chiara Melchionda, Arianna Bartoli, Antonella Foschi, Monica Schiavini, Marco Schiuma, Roberto Castelli, Maria Calloni
BACKGROUND: During coronavirus disease 2019 (COVID-19) pandemic, Helmet Continuous Positive Airway Pressure (h-CPAP) has been widely used to treat Acute Hypoxemic Respiratory Failure (AHRF). In COVID-19 patients undergoing h-CPAP a simple short peripheral catheter could be insufficient. According to the European Recommendations for Proper Indication and Use of Peripheral venous access consensus, a stable peripheral Vascular Access Device is indicated for intravenous treatment compatible with the peripheral route scheduled for more than 1 week...
May 2, 2022: Journal of Vascular Access